FUNDAMENTALS · Fundamentals · US Real Estate

CareTrust (CTRE) Fundamentals 2026 — P/E 27.3x, Revenue Analysis | SniperIQ

CareTrust (CTRE) is a US-listed Real Estate company in REIT - Healthcare Facilities with a market capitalization of

0.1B, trading at $42.83 on the NYSE. This SniperIQ fundamentals page covers CareTrust's valuation (P/E 27.3x, P/B 2.3x), profitability (net margin 71.5%), revenue ($477M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
0.1B
P/E (TTM)27.3x
Net Margin71.5%
Revenue (FY25)$477M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is CareTrust's market cap?

CareTrust (CTRE) has a market capitalization of approximately

0.1B, trading at $42.83 on the NYSE. Market cap moves with the live share price.

What is CareTrust's P/E ratio?

CareTrust's trailing twelve-month P/E ratio is 27.3x, with a price-to-book (P/B) of 2.3x. Valuation multiples are best compared with Real Estate sector peers rather than read in isolation.

How profitable is CareTrust?

CareTrust runs a net profit margin of 71.5%, a gross margin of 73.8%, and an operating margin of 61.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does CareTrust generate?

CareTrust reported revenue of $477M for fiscal year 2025, with net income of

21M and earnings per share (EPS) of 1.57. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does CareTrust pay a dividend?

CareTrust offers a trailing dividend yield of about 3.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is CareTrust financially healthy?

CareTrust carries a debt-to-equity ratio of 0.22x and a current ratio of 1.75x, with a market beta of 0.79. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is CareTrust a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CareTrust (CTRE) the key facts are: market cap

0.1B, P/E 27.3x, revenue $477M, 52-week range 30.51-43.6. Weigh valuation, profitability, growth, and balance-sheet strength against Real Estate peers and form your own view.

Track CareTrust's full fundamentals live

Get CareTrust's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Shanghai Jinqiao Export Processing Zone Development (600639) fundamentals · Gemdale (600383) fundamentals · Hefei Urban Construction Development (002208) fundamentals · Brixmor Property Group (BRX) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons